Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2002
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1246822A1 Benzofuran derivatives
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP1246801A2 Methods for the syntheses of alfentanil, sufentanil and remifentanil
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP0923562B1 Substituted p-trifluoromethylphenyluracils
10/09/2002EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/09/2002CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002US6462208 C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them
10/08/2002US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia,
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462069 Kinase inhibitors; anticancer agents
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002US6462037 Such as 7-chloro-3-methyl-5-(2-cyclopropylethynyl)-1,5-dihydro-5-(trifluoromethyl) -1,4-benzodiazepin-2-one; protease inhibitors
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6462032 Cyclic regimens utilizing indoline derivatives
10/08/2002US6461625 Nanoemulsion based on alkoxylated alkenyl succinates or alkoxylated alkenyl succinates of glucose and its uses in the cosmetics, dermatological, opthalmological and/or pharmaceutical fields
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002064583A3 Bis(alkylthio)carbenium salts
10/03/2002WO2002062766A3 Melanocortin-4 receptor binding compounds and methods of use thereof
10/03/2002WO2000034265A3 Quinoline-indole antimicrobial agents
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143004 Allosteric adenosine receptor modulators
10/03/2002US20020142023 Insecticide, miticide
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1245567A1 HIV inhibiting pyrimidine derivatives
10/02/2002EP1244655A1 Antithrombotic agents
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244652A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
10/02/2002EP1244632A1 Pyrazole derivatives which modulate human serotonin receptors
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1244623A1 A process for preparing 4-substituted piperidines
10/02/2002EP1244622A1 A process for preparing trans-2,4-disubstituted piperidines
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244449A1 Use of ketotifen as ophthalmic agent
10/02/2002EP1244446A1 Thrombopoietin mimetics
10/02/2002EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP0960107B1 6-thio-substituted paclitaxels
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002EP0690853B1 Taxanes prepared by beta-lactams and ammonium alkoxides
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372552A Pyrimidine derivatives and herbicides containing the same
10/02/2002CN1372549A Fungicidies
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1372545A 吲哚衍生物 Indole derivatives
10/02/2002CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/01/2002US6458977 Taxane derivatives as anticarcinogenic or antitumor agents
10/01/2002US6458963 Process for preparing eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates
10/01/2002US6458950 Compounds and pharmaceutical compositions containing the same
10/01/2002US6458815 Cardiovascular disorders, anticholesterol agent
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458794 Potassium channel inhibitors
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458783 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
10/01/2002US6458768 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
10/01/2002US6458474 Methine compound, material for organic luminescence element, organic luminescence element using the same
10/01/2002CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
09/2002
09/26/2002WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074747A1 Farnesyltransferase inhibitors
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 523